Walleye Trading’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.63M | Sell |
7,800
-800
| -9% | -$398K | 0.01% | 1187 |
|
|
2025
Q4 | $4.19M | Sell |
8,600
-30,600
| -78% | -$14.3M | 0.01% | 1397 |
|
|
2025
Q3 | $16.4M | Buy |
39,200
+30,300
| +340% | +$10.2M | 0.03% | 662 |
|
|
2025
Q2 | $2.56M | Buy |
8,900
+8,600
| +2,867% | +$2.57M | ﹤0.01% | 1588 |
|
|
2025
Q1 | $92.5K | Sell |
300
-1,000
| -77% | -$343K | ﹤0.01% | 3426 |
|
|
2024
Q4 | $459K | Sell |
1,300
-900
| -41% | -$331K | ﹤0.01% | 2695 |
|
|
2024
Q3 | $788K | Buy |
2,200
+1,400
| +175% | +$473K | ﹤0.01% | 2247 |
|
|
2024
Q2 | $255K | Sell |
800
-12,400
| -94% | -$3.28M | ﹤0.01% | 2935 |
|
|
2024
Q1 | $3.03M | Buy |
13,200
+10,800
| +450% | +$2.44M | 0.01% | 1453 |
|
|
2023
Q4 | $528K | Buy |
2,400
+500
| +26% | +$115K | ﹤0.01% | 3027 |
|
|
2023
Q3 | $429K | Buy |
1,900
+1,200
| +171% | +$276K | ﹤0.01% | 3073 |
|
|
2023
Q2 | $155K | Sell |
700
-100
| -13% | -$22.1K | ﹤0.01% | 3557 |
|
|
2023
Q1 | $179K | Sell |
800
-300
| -27% | -$74K | ﹤0.01% | 3581 |
|
|
2022
Q4 | $306K | Buy |
1,100
+300
| +38% | +$75.7K | ﹤0.01% | 3222 |
|
|
2022
Q3 | $168K | Sell |
800
-1,600
| -67% | -$358K | ﹤0.01% | 3810 |
|
|
2022
Q2 | $566K | Sell |
2,400
-200
| -8% | -$40.7K | ﹤0.01% | 2778 |
|
|
2022
Q1 | $466K | Sell |
2,600
-900
| -26% | -$171K | ﹤0.01% | 2979 |
|
|
2021
Q4 | $756K | Sell |
3,500
-13,900
| -80% | -$2.73M | ﹤0.01% | 2516 |
|
|
2021
Q3 | $3.21M | Buy |
17,400
+2,600
| +18% | +$512K | 0.01% | 1222 |
|
|
2021
Q2 | $2.65M | Sell |
14,800
-4,700
| -24% | -$895K | 0.01% | 1264 |
|
|
2021
Q1 | $3.26M | Sell |
19,500
-1,300
| -6% | -$217K | 0.01% | 945 |
|
|
2020
Q4 | $3.16M | Buy |
20,800
+12,200
| +142% | +$1.6M | 0.01% | 1037 |
|
|
2020
Q3 | $869K | Buy |
8,600
+700
| +9% | +$76.8K | ﹤0.01% | 1768 |
|
|
2020
Q2 | $956K | Buy |
7,900
+1,700
| +27% | +$191K | 0.01% | 1703 |
|
|
2020
Q1 | $588K | Sell |
6,200
-31,000
| -83% | -$2.95M | ﹤0.01% | 1742 |
|
|
2019
Q4 | $3.28M | Buy |
37,200
+31,900
| +602% | +$2.81M | 0.02% | 851 |
|
|
2019
Q3 | $423K | Sell |
5,300
-24,600
| -82% | -$1.98M | ﹤0.01% | 2304 |
|
|
2019
Q2 | $2.33M | Buy |
29,900
+21,700
| +265% | +$2.03M | 0.02% | 934 |
|
|
2019
Q1 | $962K | Buy |
8,200
+3,400
| +71% | +$396K | 0.01% | 1706 |
|
|
2018
Q4 | $523K | Sell |
4,800
-6,100
| -56% | -$707K | ﹤0.01% | 2432 |
|
|
2018
Q3 | $1.39M | Buy |
10,900
+6,200
| +132% | +$767K | 0.01% | 1725 |
|
|
2018
Q2 | $532K | Buy |
+4,700
| New | +$517K | ﹤0.01% | 2783 |
|
|
2017
Q1 | – | Sell |
-100
| Closed | -$14K | – | 5186 |
|
|
2016
Q4 | $14K | Hold |
100
| – | – | ﹤0.01% | 4203 |
|
|
2016
Q3 | $12K | Sell |
100
-900
| -90% | -$108K | ﹤0.01% | 4364 |
|
|
2016
Q2 | $106K | Buy |
+1,000
| New | +$112K | ﹤0.01% | 3460 |
|
|
2015
Q2 | – | Sell |
-100
| Closed | -$17K | – | 5163 |
|
|
2015
Q1 | $17K | Buy |
+100
| New | +$15.2K | ﹤0.01% | 3568 |
|
Other funds holding UTHR
ACA
VPM
VCM
Walleye Trading's UTHR Position: Q1 2026 in Review
Walleye Trading sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 7,066 shares — an estimated $3.52M sold.
Walleye Trading first reported a position in UTHR in Q2 2015 and held it in 27 quarters. The position peaked at $6M in Q2 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Walleye Trading reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
- Walleye Trading sold 7,066 United Therapeutics shares in Q1 2026, an estimated $3.52M.
- Walleye Trading first reported a position in United Therapeutics in Q2 2015 and held it in 27 quarters.
- Walleye Trading's United Therapeutics position peaked at $6M in Q2 2025.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.